The initial management of multiple myeloma in the era of novel agents: 2021 and beyond

被引：0
|
作者：
Nadeem, Omar [1 ]
Richardson, Paul G. [1 ]
机构：
[1] Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Hematol Malignancies, Boston, MD USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2021年 / 193卷 / 02期
关键词：
OPEN-LABEL; DEXAMETHASONE; LENALIDOMIDE; BORTEZOMIB; COMBINATION; MULTICENTER; CARFILZOMIB; DARATUMUMAB; PHASE-2;
D O I：
10.1111/bjh.17407
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：213 / 215
页数：3
相关论文
共 50 条
  • [21] Multiple Myeloma in the Era of Novel Agents: A Single-Center Study
    Lopes, Danielle Ovigli
    Arcuri, Leonardo
    Marques, Carolina
    Kerbauy, Mariana
    Moura, Fernando
    Helman, Ricardo
    Silva, Cinthya
    RIbeiro, Andreza
    Hamerschlak, Nelson
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S187 - S188
  • [22] Autologous Stem Cell Transplantation for Multiple Myeloma in the Era of Novel Agents
    Shimazaki, Chihiro
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (01): : 14 - 15
  • [23] Evaluation of prognostic staging systems of multiple myeloma in the era of novel agents
    Shang, Yufeng
    Jin, Yanxia
    Liu, Hailing
    Ding, Lu
    Tong, Xiqin
    Tu, Honglei
    Zang, Longkai
    Lin, Chenyao
    Hu, Jinsong
    Zhou, Fuling
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (02) : 212 - 222
  • [24] A New Prognostic Index for Multiple Myeloma Patients in the Era of Novel Agents
    Cho, Hyungwoo
    Suh, Cheolwon
    Yoon, Dok Hyun
    Park, Ji Hyun
    Kim, Shin
    Lee, Sang-wook
    Park, Chan-Sik
    Huh, Jooryung
    Lee, Kyoungmin
    Kang, Eun Hee
    Park, Jung Sun
    Park, Chan-Jeoung
    Kim, Jin Seok
    Kim, Kihyun
    BLOOD, 2014, 124 (21)
  • [25] Novel Agents in Multiple Myeloma
    Szalat, Raphael
    Munshi, Nikhil C.
    CANCER JOURNAL, 2019, 25 (01): : 45 - 53
  • [26] Autotransplants in older multiple myeloma patients: hype or hope in the era of novel agents?
    Engelhardt, Monika
    Ihorst, Gabriele
    Caers, Jo
    Guenther, Andreas
    Waesch, Ralph
    HAEMATOLOGICA, 2016, 101 (11) : 1276 - 1278
  • [27] Radiation for Multiple Myeloma in the Era of Novel Agents: Indications, Safety, and Dose Selection
    Zhang, Samuel C.
    Ballas, Leslie K.
    SEMINARS IN RADIATION ONCOLOGY, 2025, 35 (01) : 87 - 98
  • [28] Prognostic Significance of Plasmablastic Plasma Cells in the Era of Novel Agents in Multiple Myeloma
    Machet, Antoine
    Guidez, Stephanie
    Fouquet, Guillemette
    Systchenko, Thomas
    Desmier, Deborah
    Moya, Niels
    Gruchet, Cecile
    Levy, Anthony
    Sabirou, Florence
    Bobin, Arthur
    Richez, Valentine
    Dieval, Celine
    Motard, Carine
    Borde, Florence
    Durand, Geraldine
    Azais, Isabelle
    Javaugue, Vincent
    Tomowiak, Cecile
    Bouyer, Sabrina
    Ghoual, Ouda
    Dindinaud, Elodie
    Bridoux, Frank
    Sonneveld, Pieter
    Loiseau, Herve Avet
    Leleu, Xavier
    BLOOD, 2017, 130
  • [29] Therapy Related MDS/AML In Multiple Myeloma Patients In The Era Of Novel Agents
    Gertz, Morie A.
    Hayman, Suzanne R.
    Dingli, David
    Dispenzieri, Angela
    Kapoor, Prashant
    Kumar, Shaji K.
    Lacy, Martha Q.
    Leung, Nelson
    Lin, Yi
    Lust, John A.
    Mikhael, Joseph R.
    Rajkumar, S. Vincent
    Russell, Stephen J.
    Zeldenrust, Steven R.
    Kyle, Robert
    Buadi, Francis K.
    BLOOD, 2013, 122 (21)
  • [30] POST RELAPSE OUTCOMES IN YOUNG PATIENTS WITH MULTIPLE MYELOMA IN THE ERA OF NOVEL AGENTS
    Vallumsetla, N.
    Kumar, S.
    Gertz, M.
    Painuly, U.
    Dispenzieri, A.
    Lacy, M.
    Buadi, F.
    Go, R.
    Dingli, D.
    Leung, N.
    Kyle, R.
    Rajkumar, V.
    Kapoor, P.
    HAEMATOLOGICA, 2015, 100 : 257 - 258
12345